184 related articles for article (PubMed ID: 11950948)
1. Inhibition of anchorage-independent growth of transformed NIH3T3 cells by epithelial protein lost in neoplasm (EPLIN) requires localization of EPLIN to actin cytoskeleton.
Song Y; Maul RS; Gerbin CS; Chang DD
Mol Biol Cell; 2002 Apr; 13(4):1408-16. PubMed ID: 11950948
[TBL] [Abstract][Full Text] [Related]
2. Distinct involvement of cdc42 and RhoA GTPases in actin organization and cell shape in untransformed and Dbl oncogene transformed NIH3T3 cells.
Olivo C; Vanni C; Mancini P; Silengo L; Torrisi MR; Tarone G; Defilippi P; Eva A
Oncogene; 2000 Mar; 19(11):1428-36. PubMed ID: 10723134
[TBL] [Abstract][Full Text] [Related]
3. Grb2 regulation of the actin-based cytoskeleton is required for ligand-independent EGF receptor-mediated oncogenesis.
Boerner JL; Danielsen AJ; Lovejoy CA; Wang Z; Juneja SC; Faupel-Badger JM; Darce JR; Maihle NJ
Oncogene; 2003 Oct; 22(43):6679-89. PubMed ID: 14555981
[TBL] [Abstract][Full Text] [Related]
4. EPLIN regulates actin dynamics by cross-linking and stabilizing filaments.
Maul RS; Song Y; Amann KJ; Gerbin SC; Pollard TD; Chang DD
J Cell Biol; 2003 Feb; 160(3):399-407. PubMed ID: 12566430
[TBL] [Abstract][Full Text] [Related]
5. Extracellular signal-regulated kinase/mitogen-activated protein kinase regulates actin organization and cell motility by phosphorylating the actin cross-linking protein EPLIN.
Han MY; Kosako H; Watanabe T; Hattori S
Mol Cell Biol; 2007 Dec; 27(23):8190-204. PubMed ID: 17875928
[TBL] [Abstract][Full Text] [Related]
6. Epithelial Protein Lost in Neoplasm alpha (Eplin-alpha) is transcriptionally regulated by G-actin and MAL/MRTF coactivators.
Leitner L; Shaposhnikov D; Descot A; Hoffmann R; Posern G
Mol Cancer; 2010 Mar; 9():60. PubMed ID: 20236507
[TBL] [Abstract][Full Text] [Related]
7. FGF-2 induced reorganization and disruption of actin cytoskeleton through PI 3-kinase, Rho, and Cdc42 in corneal endothelial cells.
Lee HT; Kay EP
Mol Vis; 2003 Dec; 9():624-34. PubMed ID: 14685150
[TBL] [Abstract][Full Text] [Related]
8. Oligomerization of DH domain is essential for Dbl-induced transformation.
Zhu K; Debreceni B; Bi F; Zheng Y
Mol Cell Biol; 2001 Jan; 21(2):425-37. PubMed ID: 11134331
[TBL] [Abstract][Full Text] [Related]
9. Actin cytoskeleton polymerization in Dbl-transformed NIH3T3 fibroblasts is dependent on cell adhesion to specific extracellular matrix proteins.
Defilippi P; Olivo C; Tarone G; Mancini P; Torrisi MR; Eva A
Oncogene; 1997 Apr; 14(16):1933-43. PubMed ID: 9150360
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of oncogene-mediated transformation by ectopic expression of p21Waf1 in NIH3T3 cells.
Michieli P; Li W; Lorenzi MV; Miki T; Zakut R; Givol D; Pierce JH
Oncogene; 1996 Feb; 12(4):775-84. PubMed ID: 8632899
[TBL] [Abstract][Full Text] [Related]
11. Characterization of mouse epithelial protein lost in neoplasm (EPLIN) and comparison of mammalian and zebrafish EPLIN.
Maul RS; Sachi Gerbin C; Chang DD
Gene; 2001 Jan; 262(1-2):155-60. PubMed ID: 11179679
[TBL] [Abstract][Full Text] [Related]
12. EPLIN, epithelial protein lost in neoplasm.
Maul RS; Chang DD
Oncogene; 1999 Dec; 18(54):7838-41. PubMed ID: 10618726
[TBL] [Abstract][Full Text] [Related]
13. EPLIN: a fundamental actin regulator in cancer metastasis?
Collins RJ; Jiang WG; Hargest R; Mason MD; Sanders AJ
Cancer Metastasis Rev; 2015 Dec; 34(4):753-64. PubMed ID: 26350886
[TBL] [Abstract][Full Text] [Related]
14. The COOH-terminal domain of FLI-1 is necessary for full tumorigenesis and transcriptional modulation by EWS/FLI-1.
Arvand A; Welford SM; Teitell MA; Denny CT
Cancer Res; 2001 Jul; 61(13):5311-7. PubMed ID: 11431376
[TBL] [Abstract][Full Text] [Related]
15. Cytoskeletal organization in tropomyosin-mediated reversion of ras-transformation: Evidence for Rho kinase pathway.
Shah V; Bharadwaj S; Kaibuchi K; Prasad GL
Oncogene; 2001 Apr; 20(17):2112-21. PubMed ID: 11360195
[TBL] [Abstract][Full Text] [Related]
16. The growth and tumor suppressor NORE1A is a cytoskeletal protein that suppresses growth by inhibition of the ERK pathway.
Moshnikova A; Frye J; Shay JW; Minna JD; Khokhlatchev AV
J Biol Chem; 2006 Mar; 281(12):8143-52. PubMed ID: 16421102
[TBL] [Abstract][Full Text] [Related]
17. Imaging of dynamic changes of the actin cytoskeleton in microextensions of live NIH3T3 cells with a GFP fusion of the F-actin binding domain of moesin.
Litman P; Amieva MR; Furthmayr H
BMC Cell Biol; 2000; 1():1. PubMed ID: 11112983
[TBL] [Abstract][Full Text] [Related]
18. ZNF185, an actin-cytoskeleton-associated growth inhibitory LIM protein in prostate cancer.
Zhang JS; Gong A; Young CY
Oncogene; 2007 Jan; 26(1):111-22. PubMed ID: 16799630
[TBL] [Abstract][Full Text] [Related]
19. Desensitization of the PDGFbeta receptor by modulation of the cytoskeleton: the role of p21(Ras) and Rho family GTPases.
Stice LL; Forman LW; Hahn CS; Faller DV
Exp Cell Res; 2002 Apr; 275(1):17-30. PubMed ID: 11925102
[TBL] [Abstract][Full Text] [Related]
20. Retroviral gene transfer of dominant negative raf-1 mutants suppresses ha-ras-induced transformation and delays tumor formation.
Heinicke T; Radziwill G; Nawrath M; Rommel C; Pavlovic J; Moelling K
Cancer Gene Ther; 2000 May; 7(5):697-706. PubMed ID: 10830717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
